Loading chart…
PRE-MARKET
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as antidiabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, GLP-1, and vitamins/minerals/nutrients.
Eris Lifesciences Limited (ERIS) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ERIS share price is ₹1,252.70 (+1.85% today), with a market capitalisation of ₹174B and a price-to-earnings (P/E) ratio of 24.4. MarketRipple tracks the ERIS investment thesis, the ripple-chain impact of market events on Eris Lifesciences Limited, and the Healthcare sector outlook.
Open
₹1,241.80
High
₹1,272.90
Low
₹1,231.00
Prev. Close
₹1,229.90
52W High
₹1,740.00
52W Low
₹1,069.00
Day range
₹1,231.00–₹1,272.90
52-week range
₹1,069.00–₹1,740.00
Volume
11K
P/E
24.4
ROE
18.8%
D/E
0.60
Margin
21.4%
Eris Lifesciences Limited (NSE: ERIS) is currently trading at ₹1,252.70 (+1.85%).
Eris Lifesciences Limited's market capitalization is ₹174B.
Eris Lifesciences Limited's price-to-earnings (P/E) ratio is 24.4.
Eris Lifesciences Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Eris Lifesciences Limited currently reads strongly positive, based on 10 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.